Compare Inovio Pharmaceuticals Inc (INO) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Vital Farms Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.76 (market cap $78.55M), while Vital Farms Inc trades at $11.48 (market cap $496.50M). The key difference: Vital Farms Inc is far larger — about 6.3× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | VITL | |
|---|---|---|
Market Cap | $78.55M | $496.50M |
Sector | Health | Consumer Staples |
52-Week High | $2.87 | $52.41 |
52-Week Low | $0.66 | $8.28 |
Enterprise Value | $49.56M | $583.51M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $0.76, up 2.74% today, but remains in a bearish technical trend. The company shows minimal revenue of $65K against high operating losses, with a net income margin of -130,000%. Recent quarterly EPS has beaten expectations. Analyst consensus is bullish with a $3.25 price target, but the stock faces significant fundamental challenges including negative cash flow and high valuation multiples.
The outlook hinges on FDA approval of INO-3107 in October 2026, a binary event that could drive substantial upside. However, persistent cash burn, negative profitability, and ongoing shareholder litigation present high risks. Investors should weigh the potential catalyst against the company's weak financial health and operational execution challenges.
VITL trades at $11.48, up 1.95% on the day, but faces significant technical headwinds with a bearish moving average signal. The company reported mixed Q2 2026 results, beating revenue estimates but posting a $0.47 per share loss amid industry oversupply challenges. Recent $125 million term loan financing provides liquidity support during this transitional period.
While analyst consensus remains positive with a $13.00 price target, near-term risks include margin compression from elevated costs and competitive pricing pressures. The stock's attractive P/S ratio of 0.67 offers value potential if the company can navigate current industry headwinds and return to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
